期刊文献+
共找到4篇文章
< 1 >
每页显示 20 50 100
Insights into the mechanism of L-malic acid on drip loss of chicken meat under commercial conditions
1
作者 Haijun Sun Xue Yan +4 位作者 Lu Wang Ruimin Zhu meixia chen Jingdong Yin Xin Zhang 《Journal of Animal Science and Biotechnology》 SCIE CAS CSCD 2024年第3期1312-1324,共13页
Background A deterioration in the meat quality of broilers has attracted much more attention in recent years.L-malic acid(MA)is evidenced to decrease meat drip loss in broilers,but the underlying molecular mechanisms ... Background A deterioration in the meat quality of broilers has attracted much more attention in recent years.L-malic acid(MA)is evidenced to decrease meat drip loss in broilers,but the underlying molecular mechanisms are still unclear.It’s also not sure whether the outputs obtained under experimental conditions can be obtained in a com-mercial condition.Here,we investigated the effects and mechanisms of dietary MA supplementation on chicken meat drip loss at large-scale rearing.Results Results showed that the growth performance and drip loss were improved by MA supplementation.Meat metabolome revealed that L-2-aminoadipic acid,β-aminoisobutyric acid,eicosapentaenoic acid,and nicotinamide,as well as amino acid metabolism pathways connected to the improvements of meat quality by MA addition.The transcriptome analysis further indicated that the effect of MA on drip loss was also related to the proper immune response,evidenced by the enhanced B cell receptor signaling pathway,NF-κB signaling pathway,TNF signaling pathway,and IL-17 signaling pathway.Conclusions We provided evidence that MA decreased chicken meat drip loss under commercial conditions.Metabolome and transcriptome revealed a comprehensive understanding of the underlying mechanisms.Together,MA could be used as a promising dietary supplement for enhancing the water-holding capacity of chicken meat. 展开更多
关键词 Drip loss Immune response L-malic acid Meat quality METABOLOME TRANSCRIPTOME
下载PDF
Phase I study of CAR-T cells with PD-1 and TCR disruption in mesothelin-positive solid tumors 被引量:12
2
作者 Zhenguang Wang Na Li +14 位作者 Kaichao Feng meixia chen Yan Zhang Yang Liu Qingming Yang Jing Nie Na Tang Xingying Zhang chen cheng Lianjun Shen Jiaping He Xun Ye Wei Cao Haoyi Wang Weidong Han 《Cellular & Molecular Immunology》 SCIE CAS CSCD 2021年第9期2188-2198,共11页
Programmed cell death protein-1(PD-1)-mediated immunosuppression has been proposed to contribute to the limited clinical efficacy of chimeric antigen receptor T(CAR-T)cells in solid tumors.We generated PD-1 and T cell... Programmed cell death protein-1(PD-1)-mediated immunosuppression has been proposed to contribute to the limited clinical efficacy of chimeric antigen receptor T(CAR-T)cells in solid tumors.We generated PD-1 and T cell receptor(TCR)deficient mesothelin-specific CAR-T(MPTK-CAR-T)cells using CRISPR-Cas9 technology and evaluated them in a dose-escalation study.A total of 15 patients received one or more infusions of MPTK-CAR-T cells without prior lymphodepletion.No dose-limiting toxicity or unexpected adverse events were observed in any of the 15 patients.The best overall response was stable disease(2/15 patients).Circulating MPTK-CAR-T cells peaked at days 7–14 and became undetectable beyond 1 month.TCR-positive CAR-T cells rather than TCR-negative CAR-T cells were predominantly detected in effusion or peripheral blood from three patients after infusion.We further confirmed the reduced persistence of TCR-deficient CAR-T cells in animal models.Our results establish the preliminary feasibility and safety of CRISPR-engineered CAR-T cells with PD-1 disruption and suggest that the natural TCR plays an important role in the persistence of CAR-T cells when treating solid tumors. 展开更多
关键词 CAR-T CRISPR-Cas9 PD-1 TCR MESOTHELIN
原文传递
An analytical biomarker for treatment of patients with recurrent B-ALL after remission induced by infusion of anti-CD19 chimeric antigen receptor T(CAR-T) cells 被引量:6
3
作者 Yajing Zhang Wenying Zhang +12 位作者 Hanren Dai Yao Wang Fengxia Shi Chunmeng Wang Yelei Guo Yang Liu meixia chen Kaichao Feng Yan Zhang Chuanjie Liu Qingming Yang Suxia Li Weidong Han 《Science China(Life Sciences)》 SCIE CAS CSCD 2016年第4期379-385,共7页
Anti-CD19 chimeric antigen receptor-modified T(CAR-T-19) cells have emerged as a powerful targeted immunotherapy for B-cell lineage acute lymphoblastic leukemia with a remarkable clinical response in recent trials. No... Anti-CD19 chimeric antigen receptor-modified T(CAR-T-19) cells have emerged as a powerful targeted immunotherapy for B-cell lineage acute lymphoblastic leukemia with a remarkable clinical response in recent trials. Nonetheless, few data are available on the subsequent clinical monitoring and treatment of the patients, especially those with disease recurrence after CAR-T-19 cell infusion. Here, we analyzed three patients who survived after our phase I clinical trial and who were studied by means of biomarkers reflecting persistence of CAR-T-19 cells in vivo and predictive factors directing further treatment. One patient achieved 9-week sustained complete remission and subsequently received an allogeneic hematopoietic stem cell transplant. Another patient who showed relapse after 20 weeks without detectable leukemia in the cerebrospinal fluid after CAR-T-19 cell treatment was able to achieve a morphological remission under the influence of stand-alone low-dose chemotherapeutic agents. The third patient gradually developed extensive extramedullary involvement in tissues with scarce immune-cell infiltration during a long period of hematopoietic remission after CAR-T-19 cell therapy. Long-term and discontinuous increases in serum cytokines(mainly interleukin 6 and C-reactive protein) were identified in two patients(Nos. 1 and 6) even though only a low copy number of CAR molecules could be detected in their peripheral blood. This finding was suggestive of persistent functional activity of CAR-T-19 cells. Combined analyses of laboratory biomarkers with their clinical manifestations before and after salvage treatment showed that the persistent immunosurveillance mediated by CAR-T-19 cells would inevitably potentiate the leukemia-killing effectiveness of subsequent chemotherapy in patients who showed relapse after CAR-T-19-induced remission. 展开更多
关键词 chimeric antigen receptor T cells B-cell acute lymphoblastic leukemia biomarker immunosurveillance microenvironment
原文传递
Theoretical Modeling and Analysis of Vibroacoustic Characteristics of an Acoustic Metamaterial Plate
4
作者 Ting Wang Hanbei Guo +1 位作者 meixia chen Wenkai Dong 《Acta Mechanica Solida Sinica》 SCIE EI CSCD 2022年第5期775-786,共12页
Locally resonant metamaterial plates with subwavelength bandgaps can be exploited for the simultaneous control of structural vibrations and acoustic radiation.The present work theoretically investigates the vibroacous... Locally resonant metamaterial plates with subwavelength bandgaps can be exploited for the simultaneous control of structural vibrations and acoustic radiation.The present work theoretically investigates the vibroacoustic characteristics of a metamaterial plate with periodic lateral local resonance.The high accuracy of the presented method is evident from the consistency of the cross mobility of the metamaterial plate calculated with the finite element technique.The modal superposition approach and Rayleigh integral technique are adopted to formulate the mean square velocity and acoustic radiation power in terms of the structural deflection and sound pressure to capture the vibroacoustic coupling characteristics of the metamaterial plate and the surrounding environment.Large vibration suppression and sound reduction with high radiation efficiency can be observed within the frequency ranges of interest.The near-field sound intensity and far-field acoustic pressure distributions inside and outside the bandgaps are plotted and analyzed.The results from this work can be utilized to set design guidelines for metamaterial design to achieve prescribed vibroacoustic characteristics. 展开更多
关键词 Vibroacoustic characteristics Metamaterial plate with lateral local resonance Near-field sound intensity Far-field acoustic pressure
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部